The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer.
about
Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrierThe Origin and Activities of IgA1-Containing Immune Complexes in IgA NephropathyEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsEfficient hepatic delivery of drugs: novel strategies and their significanceLocal targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicinLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasoundFixation methods for electron microscopy of human and other liver.Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirusAdenoviral targeting of gene expression to tumors.Cancer targeted therapeutics: From molecules to drug delivery vehicles.Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeabilityFormation of fenestrae in murine liver sinusoids depends on plasmalemma vesicle-associated protein and is required for lipoprotein passage.The AAV9 receptor and its modification to improve in vivo lung gene transfer in miceFcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes.Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts.Systemic Administration of siRNA via cRGD-containing Peptide.Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus)Magnetic Nanoparticles: Material Engineering and Emerging Applications in Lithography and Biomedicine.MicroRNAs in Liver Health and DiseaseEarly effect of a single intravenous injection of ethanol on hepatic sinusoidal endothelial fenestrae in rabbits.Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumorX-ray computed tomography imaging of a tumor with high sensitivity using gold nanoparticles conjugated to a cancer-specific antibody via polyethylene glycol chains on their surfaceHelper-Dependent Adenoviral Vectors.The role of liver sinusoidal cells in hepatocyte-directed gene transfer.Regulatory mechanisms, prophylaxis and treatment of vascular leakage following severe trauma and shock.Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.Action and reaction: the biological response to siRNA and its delivery vehicles.Reversibly crosslinked nanocarriers for on-demand drug delivery in cancer treatment.Sorting Out Pandora's Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Atomic Force Microscopy Reveals the Dynamic Morphology of Fenestrations in Live Liver Sinusoidal Endothelial Cells.Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle.Cationic switchable lipids: pH-triggered molecular switch for siRNA delivery.Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics.Delivery strategies: RNA interference in agriculture and human health.Evaluating the anticancer properties of liposomal copper in a nude xenograft mouse model of human prostate cancer: formulation, in vitro, in vivo, histology and tissue distribution studies.Focus on cutaneous and uveal melanoma specificities.Development of lipidoid-siRNA formulations for systemic delivery to the liver.Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes.
P2860
Q24644639-7C76F7B5-8ECC-4D1E-B86A-AB5063FE4E9BQ26752555-E4366835-5349-498E-90C5-7FA02AEB8CE4Q26996159-5E18441B-BC51-46D2-8EA3-C2A83ACA41DAQ27007518-BEE4755C-F8B4-4F40-87C7-4A244AEA3A97Q28533299-C2D03283-1FC0-4025-9459-18522D9B6CC7Q30366990-64D20E24-BEEA-4C52-A02D-07E0A23BB03FQ30446996-1E91CC05-B71C-4E40-B9F8-4879794C3ED1Q33607941-67580CF2-B66F-435D-85A0-86EEDB5EA8B1Q33690982-56687F87-391F-4EC7-9622-940FC4930788Q33862714-C60B63FB-FDFD-4BD3-A76F-786E5DD02C9EQ33887986-9AFB9D3E-2217-4862-9F0E-05050412C7B1Q34083937-351F51AE-EF0A-4499-B1FB-6D0D65B5E64BQ34775930-66D1A8DD-925C-49F7-BEE6-6D55E4F67527Q35015807-CDEFFF79-652A-4F9C-8304-EC747B446D40Q35612397-EA84987D-B426-4D9A-8E4C-5D50233EB251Q35613017-4DFDA756-FBEA-45DB-B09E-CF89F83CBF1BQ35989535-0AB1622C-0549-4BAE-8005-DDF22B9EF7BDQ36055718-F082CF49-9D01-475D-8453-3084E53F8B7BQ36283461-32771EFC-7C98-4A0A-A840-4E8F38CF8FB2Q36739805-C17D7BB7-DD09-4EA3-8D29-9C2C54B0D3C8Q37274023-569C7F82-C139-4473-A8DA-22E24B92213EQ37275063-945B6BB6-DDCE-4228-A277-CF5005542761Q37403163-E9EBC616-90CE-453E-99BA-993B8D214031Q37582126-3974D1AD-8AB6-4AA9-A2AD-92AB4683D297Q37641568-5565841C-47C7-4694-BDCE-B4637B062535Q37726288-7B2D56FE-5E63-4D75-B512-E4165FD6C3C4Q37976494-BA3687AE-DAA6-47B3-AA8B-D72137D6FD78Q37976576-CFA0B48D-3196-4326-8D66-FFEE8902A611Q38074441-65DE3D03-3737-487F-BC04-ABF6C34F3BA5Q38209337-E87A56FE-972C-40EB-9055-63CADD710266Q38614156-08D6D264-BE14-4F82-B177-99018933FD1CQ38628160-AE42F2FC-5F67-44B7-9E1D-79C8A05DCE8EQ38786095-7F3E94AB-790A-4DA7-8446-590A36848F57Q38788622-AC06D302-600F-4BC7-B518-61E6736977BEQ38802167-6728639E-F712-4BA6-A913-9C3D98D9EBC9Q38851942-CF017C0F-BD93-41BE-88F4-361C11B479E2Q38993045-D1D032C2-A313-491E-89A7-94E3B7E32D6DQ39312161-30F21AB8-3C28-4E1D-A95C-54EE13FB609DQ39506235-42C0A4F8-29AD-4156-943A-9085B7D4AE6DQ39631925-374307C7-BD50-42AF-8CB4-2022E4023C4F
P2860
The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The size of endothelial fenest ...... tocyte-directed gene transfer.
@en
The size of endothelial fenest ...... tocyte-directed gene transfer.
@nl
type
label
The size of endothelial fenest ...... tocyte-directed gene transfer.
@en
The size of endothelial fenest ...... tocyte-directed gene transfer.
@nl
prefLabel
The size of endothelial fenest ...... tocyte-directed gene transfer.
@en
The size of endothelial fenest ...... tocyte-directed gene transfer.
@nl
P2093
P2860
P356
P1433
P1476
The size of endothelial fenest ...... tocyte-directed gene transfer.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2008.60
P577
2008-04-10T00:00:00Z
P5875
P6179
1023207801